Legal & General Group PLC Oyster Point Pharma, Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$3.6 - $11.2 $3,182 - $9,900	-884 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.17 - $18.96 $233 - $436	-23 Reduced 2.54%	884 $16,000
Q2 2021 Aug 12, 2021	BUY	$16.25 - $21.51 $4,078 - $5,399	251 Added 38.26%	907 $16,000
Q1 2021 May 17, 2021	SELL	$17.92 - $25.86 $1,272 - $1,836	-71 Reduced 9.77%	656 $12,000
Q3 2020 Nov 13, 2020	SELL	$17.83 - $29.12 $2,941 - $4,804	-165 Reduced 18.5%	727 $15,000
Q1 2020 May 14, 2020	SELL	$23.65 - $40.96 $5,392 - $9,338	-228 Reduced 20.36%	892 $31,000
Q4 2019 Feb 13, 2020	BUY	$13.55 - $26.15 $15,176 - $29,288	1,120 New	1,120 $27,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.